RMD
RESMED INC
NYSE, OTC · CIK 943819
Last close218.89
Daily change-2.26 (-1.02%)
10 Years gain+267.51%
Dividends TTM2.46 (+12.33%)
Dividend yield1.11%
Fundamental Analysis
RMD · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 0630
Fundamental
84.9Momentum
70.6Acceleration
75.4Confidence
100.0Annual Revenue18
Quarterly Revenue51
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth17.7 / 25
Quality21.5 / 25
Capital Efficiency18.2 / 20
Balance Sheet14.6 / 15
Shareholder Economics8.9 / 10
Forward Indicators4.0 / 5
Signals
Gross margin expansionGross margin improved by 3.5344 percentage points.
Operating leverageOperating margin improved by 4.1268 percentage points.
FCF growthFree cash flow grew 47.1379%.
ROIC expansionROIC improved by 6.5282 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 1.192%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM12.64%OK
Revenue CAGR 3Y10.21%OK
Gross Margin61.24%OK
Operating Margin34.01%OK
FCF Margin32.91%OK
FCF Growth47.14%OK
ROIC27.01%OK
Incremental Operating Margin 3Y43.72%OK
Net Debt / CFO-0.65xOK
Diluted Share Growth 1Y-1.19%OK
SBC / Revenue1.84%OK
SBC / FCF5.6%OK
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Jun 30, 2026 | $5.65B | $3.45B | $1.89B | $1.81B | $1.65B | 61.06% | 33.37% | 29.18% | 27.39% | 146.05M |
| 2026 FY Jun 30, 2025 | $5.15B | $3.05B | $1.69B | $1.75B | $1.66B | 59.36% | 32.75% | 32.29% | 26.21% | 147.34M |
| 2026 FY Jun 30, 2024 | $4.69B | $2.66B | $1.32B | $1.40B | $1.30B | 56.67% | 28.17% | 27.78% | 20% | 147.55M |
| 2025 FY Jun 30, 2023 | $4.22B | $2.36B | $1.13B | $693.30M | $573.63M | 55.78% | 26.8% | 13.58% | 20.08% | 147.46M |
| 2024 FY Jun 30, 2022 | $3.58B | $2.02B | $1.00B | $351.15M | $216.31M | 56.57% | 27.96% | 6.05% | 22.91% | 147.04M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $5.48B | sum latest 4 fiscal quarters Revenue | OK | 0000943819-26-000025, 0000943819-25-000090 |
| Revenue Growth TTM | 12.64% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0000943819-26-000025, 0000943819-25-000090 |
| Revenue CAGR 3Y | 10.21% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0000943819-26-000047 |
| Revenue CAGR 5Y | 12.08% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0000943819-26-000047 |
| Gross Profit CAGR 3Y | 13.58% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0000943819-26-000047 |
| Operating Income Growth | 28.2% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0000943819-26-000025, 0000943819-25-000090 |
| FCF Growth | 47.14% | FCF_current / FCF_prior_year - 1 | OK | 0000943819-26-000025, 0000943819-26-000007 |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 61.24% | Gross Profit / Revenue | OK | 0000943819-26-000025, 0000943819-25-000090 |
| Operating Margin | 34.01% | Operating Income / Revenue | OK | 0000943819-26-000025, 0000943819-25-000090 |
| FCF Margin | 32.91% | (CFO - CapEx) / Revenue | OK | 0000943819-26-000025, 0000943819-26-000007 |
| ROIC | 27.01% | NOPAT / Average Invested Capital | OK | 0000943819-26-000025, 0000943819-25-000090 |
| Net Debt / CFO | -0.65x | Net Debt / CFO | OK | 0000943819-26-000025, 0000943819-26-000007 |
| Current Ratio | 3.01x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 4.11x | (Cash + Short-term Investments) / Total Debt | OK | 0000943819-26-000025 |